U.S. flag

An official website of the United States government

NM_004946.3(DOCK2):c.215A>T (p.Glu72Val) AND DOCK2 deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 29, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001306879.6

Allele description

NM_004946.3(DOCK2):c.215A>T (p.Glu72Val)

Gene:
DOCK2:dedicator of cytokinesis 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q35.1
Genomic location:
Preferred name:
NM_004946.3(DOCK2):c.215A>T (p.Glu72Val)
HGVS:
  • NC_000005.10:g.169670588A>T
  • NG_051800.1:g.38342A>T
  • NM_004946.3:c.215A>TMANE SELECT
  • NP_004937.1:p.Glu72Val
  • LRG_1227t1:c.215A>T
  • LRG_1227:g.38342A>T
  • LRG_1227p1:p.Glu72Val
  • NC_000005.9:g.169097592A>T
  • NR_156756.1:n.267A>T
Protein change:
E72V
Links:
dbSNP: rs1375534866
NCBI 1000 Genomes Browser:
rs1375534866
Molecular consequence:
  • NM_004946.3:c.215A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_156756.1:n.267A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
DOCK2 deficiency
Synonyms:
Immunodeficiency 40
Identifiers:
MONDO: MONDO:0014637; MedGen: C4225328; Orphanet: 447737; OMIM: 616433

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001496265Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(May 29, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV001496265.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with DOCK2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with valine at codon 72 of the DOCK2 protein (p.Glu72Val). The glutamic acid residue is weakly conserved and there is a moderate physicochemical difference between glutamic acid and valine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024